Matches in SemOpenAlex for { <https://semopenalex.org/work/W4328108224> ?p ?o ?g. }
- W4328108224 abstract "The inflammasome regulates innate immunity by serving as a signaling platform. The Nod‑like receptor protein 3 (NLRP3) inflammasome, equipped with NLRP3, the adaptor protein apoptosis‑associated speck‑like protein (ASC) and pro‑caspase‑1, is by far the most extensively studied and well‑characterized inflammasome. A variety of stimuli can activate the NLRP3 inflammasome. When activated, the NLRP3 protein recruits the adaptor ASC protein and activates pro‑caspase‑1, resulting in inflammatory cytokine maturation and secretion, which is associated with inflammation and pyroptosis. However, the aberrant activation of the NLRP3 inflammasome has been linked to various inflammatory diseases, including atherosclerosis, ischemic stroke, Alzheimer's disease, diabetes mellitus and inflammatory bowel disease. Therefore, the NLRP3 inflammasome has emerged as a promising therapeutic target for inflammatory diseases. In the present review, systematic searches were performed using ‘NLRP3 inhibitor(s)’ and ‘inflammatory disease(s)’ as key words. By browsing the literature from 2012 to 2022, 100 articles were retrieved, of which 35 were excluded as they were reviews, editorials, retracted or unavailable online, and 65 articles were included. According to the retrieved literature, the current understanding of NLRP3 inflammasome pathway activation in inflammatory diseases was summarize, and inhibitors of the NLRP3 inflammasome pathway targeting the NLRP3 protein and other inflammasome components or products were highlighted. Additionally, the present review briefly discusses the current novel efforts in clinical research." @default.
- W4328108224 created "2023-03-22" @default.
- W4328108224 creator A5007646857 @default.
- W4328108224 creator A5010817623 @default.
- W4328108224 creator A5013972195 @default.
- W4328108224 creator A5042486928 @default.
- W4328108224 creator A5061072388 @default.
- W4328108224 creator A5062777663 @default.
- W4328108224 creator A5063213998 @default.
- W4328108224 creator A5064627383 @default.
- W4328108224 creator A5071951805 @default.
- W4328108224 creator A5084815933 @default.
- W4328108224 date "2023-03-21" @default.
- W4328108224 modified "2023-10-16" @default.
- W4328108224 title "Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review)" @default.
- W4328108224 cites W1756750202 @default.
- W4328108224 cites W1864325817 @default.
- W4328108224 cites W1927491384 @default.
- W4328108224 cites W1934414823 @default.
- W4328108224 cites W1977159891 @default.
- W4328108224 cites W1987329700 @default.
- W4328108224 cites W1993976394 @default.
- W4328108224 cites W1994473516 @default.
- W4328108224 cites W1995721213 @default.
- W4328108224 cites W2004387196 @default.
- W4328108224 cites W2018011543 @default.
- W4328108224 cites W2025436502 @default.
- W4328108224 cites W2026400708 @default.
- W4328108224 cites W2028519649 @default.
- W4328108224 cites W2031796413 @default.
- W4328108224 cites W2037772830 @default.
- W4328108224 cites W2051273661 @default.
- W4328108224 cites W2053636354 @default.
- W4328108224 cites W2057039052 @default.
- W4328108224 cites W2058707285 @default.
- W4328108224 cites W2077549620 @default.
- W4328108224 cites W2079158266 @default.
- W4328108224 cites W2079882002 @default.
- W4328108224 cites W2089814700 @default.
- W4328108224 cites W2099645158 @default.
- W4328108224 cites W2108373994 @default.
- W4328108224 cites W2114072930 @default.
- W4328108224 cites W2118403357 @default.
- W4328108224 cites W2118918019 @default.
- W4328108224 cites W2128190429 @default.
- W4328108224 cites W2132161879 @default.
- W4328108224 cites W2136877983 @default.
- W4328108224 cites W2137435338 @default.
- W4328108224 cites W2140637559 @default.
- W4328108224 cites W2142943752 @default.
- W4328108224 cites W2158591358 @default.
- W4328108224 cites W2169267616 @default.
- W4328108224 cites W2254807163 @default.
- W4328108224 cites W2295605120 @default.
- W4328108224 cites W2461915818 @default.
- W4328108224 cites W2464242197 @default.
- W4328108224 cites W2515107329 @default.
- W4328108224 cites W2527001605 @default.
- W4328108224 cites W2566478676 @default.
- W4328108224 cites W2574419680 @default.
- W4328108224 cites W2577474303 @default.
- W4328108224 cites W2594548297 @default.
- W4328108224 cites W2604128719 @default.
- W4328108224 cites W2605402511 @default.
- W4328108224 cites W2607078725 @default.
- W4328108224 cites W2607216106 @default.
- W4328108224 cites W2623847043 @default.
- W4328108224 cites W2737497027 @default.
- W4328108224 cites W2739362116 @default.
- W4328108224 cites W2740616875 @default.
- W4328108224 cites W2743254891 @default.
- W4328108224 cites W2752871740 @default.
- W4328108224 cites W2766642320 @default.
- W4328108224 cites W2770607578 @default.
- W4328108224 cites W2777384066 @default.
- W4328108224 cites W2783453358 @default.
- W4328108224 cites W2789997601 @default.
- W4328108224 cites W2790572647 @default.
- W4328108224 cites W2791711864 @default.
- W4328108224 cites W2794371126 @default.
- W4328108224 cites W2799286389 @default.
- W4328108224 cites W2805060620 @default.
- W4328108224 cites W2805134165 @default.
- W4328108224 cites W2806590169 @default.
- W4328108224 cites W2810072585 @default.
- W4328108224 cites W2886707220 @default.
- W4328108224 cites W2887126044 @default.
- W4328108224 cites W2888057265 @default.
- W4328108224 cites W2889841091 @default.
- W4328108224 cites W2895388575 @default.
- W4328108224 cites W2896559737 @default.
- W4328108224 cites W2898603313 @default.
- W4328108224 cites W2902195261 @default.
- W4328108224 cites W2913315260 @default.
- W4328108224 cites W2913506254 @default.
- W4328108224 cites W2913750688 @default.
- W4328108224 cites W2915252464 @default.
- W4328108224 cites W2916165910 @default.
- W4328108224 cites W2927966495 @default.
- W4328108224 cites W2928482340 @default.